All In MedTech

Device Trial Radar · NCT03991455

Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)

Last checked: Nov 20, 2026Latest source record: Jul 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

17

Actual

Start

Oct 25, 2019

Primary completion

May 1, 2022

Study completion May 1, 2022

Sponsor

Lead sponsor
Escala Medical LTDNot on our public-company list
Sponsor type
Industry
First posted
Jun 19, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to further evaluate this minimally invasive SSLF technique with respect to safety, clinical effectiveness, and patient satisfaction. The procedure will be performed in women electing to undergo surgical repair of their prolapse who wish to preserve their uterus, and will be evaluated using standardized measures and questionnaires.

Conditions

  • Pelvic Organ Prolapse

Interventions

  • Apyx deviceDevice

    The Apyx device enables approximation and fixation of the vaginal apex to the SSL using a deployable anchoring system.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in PFDI-20 Prolapse Subscale (POPDI-6) scoreTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rambam Medical Center

    Haifa, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.